BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System

Westport, CT, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the US Patent Office has allowed another foundational patent including additional 29 patent claims covering its PURE EPTM System. The patent application number 16/271,466 entitled "Systems and Methods for…